Novartis (Sweden)-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2010

  1. Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study

    Leukemia Research, Vol. 34, Núm. 9, pp. 1143-1150

  2. Effect of nateglinide on the incidence of diabetes and cardiovascular events

    New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1463-1476

  3. Effect of valsartan on the incidence of diabetes and cardiovascular events

    New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1477-1490

  4. Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients

    Pulmonary Pharmacology and Therapeutics, Vol. 23, Núm. 5, pp. 438-444

1999

  1. Distribution of the group II metabotropic glutamate receptors (mGluR2/3) in the enteric nervous system of the rat

    Neuroscience Letters, Vol. 276, Núm. 2, pp. 91-94